ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,661Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 3734

$1.07M Total Retail Price of All Prescriptions

Rank: 71 out of 3734

578 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 578 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 578 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 21,129 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 1,332 1,310 1 10
METOPROLOL TARTRATE 806 770 2 6
LEVOTHYROXINE SODIUM 795 760 3 2
SIMVASTATIN 729 688 4 1
AMLODIPINE BESYLATE 679 650 5 5
FUROSEMIDE 619 586 6 7
LISINOPRIL 616 577 7 3
CITALOPRAM HBR 568 538 8 16
OMEPRAZOLE 495 459 9 4
PRAVASTATIN SODIUM 492 459 10 15
GABAPENTIN 422 386 11 17
GLIMEPIRIDE 370 348 12 37
METFORMIN HCL 339 290 13 8
DONEPEZIL HCL 318 318 14 25
FAMOTIDINE 282 230 15 60
BUMETANIDE 264 256 16 78
POTASSIUM CHLORIDE 247 231 17 19
KLOR-CON M20 243 222 18 48
METOPROLOL SUCCINATE 238 229 19 14
LANTUS 235 222 20 54
NAMENDA 229 229 21 44
RISPERIDONE 199 186 22 62
NOVOLOG 191 171 23 112
CARBIDOPA-LEVODOPA 189 189 24 92
ISOSORBIDE MONONITRATE ER 184 184 25 34
SERTRALINE HCL 183 177 26 18
ATORVASTATIN CALCIUM 178 165 27 11
CLOPIDOGREL 176 164 28 23
DIGOXIN 163 162 29 43
CARVEDILOL 162 155 30 30
METOLAZONE 160 149 31 174
TAMSULOSIN HCL 158 140 32 29
KLOR-CON M10 156 156 33 115
DIOVAN 153 129 34 31
ESCITALOPRAM OXALATE 151 136 35 68
HYDROCODONE-ACETAMINOPHEN 150 121 S3 36 12
TRAZODONE HCL 147 143 37 49
LOSARTAN POTASSIUM 147 137 37 21
ALLOPURINOL 145 132 39 33
PLAVIX 144 140 40 39
NITROGLYCERIN PATCH 127 127 41 171
QUETIAPINE FUMARATE 123 114 42 82
CEFUROXIME 122 115 43 168
ATENOLOL 119 100 44 13
TRIAMTERENE-HCTZ 119 104 44 73
DILTIAZEM 24HR CD 117 115 46 97
AZITHROMYCIN 114 107 47 38
NEXIUM 112 102 48 36
MIRTAZAPINE 109 100 49 45
HUMALOG 101 95 50 146
TRAMADOL HCL 99 92 51 20
LEVOFLOXACIN 98 85 52 116
HYDROCHLOROTHIAZIDE 97 97 53 9
FINASTERIDE 97 97 53 88
NOVOLOG MIX 70-30 96 83 55 265
BRIMONIDINE TARTRATE 92 92 56 371
IPRATROPIUM-ALBUTEROL 89 69 57 98
TRAVATAN Z 88 88 58 278
CEPHALEXIN 87 83 59 120
LEVETIRACETAM 87 76 59 105
SYNTHROID 86 86 61 47
OXYBUTYNIN CHLORIDE ER 85 75 62 141
FLUOXETINE HCL 84 80 63 61
JANUVIA 83 63 64 50
POLYETHYLENE GLYCOL 3350 83 70 64 53
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 78 64 117
PREDNISONE 82 80 67 42
PAROXETINE HCL 80 79 68 59
CEFDINIR 80 77 68 300
ALENDRONATE SODIUM 77 77 70 26
FENTANYL 75 72 S2 71 65
PHENYTOIN SODIUM EXTENDED 73 73 72 149
LISINOPRIL-HYDROCHLOROTHIAZIDE 73 73 72 27
OXYCODONE-ACETAMINOPHEN 72 58 S2 74 51
VERAPAMIL ER 72 72 74 96
NYSTOP 71 64 76 187
MELOXICAM 71 68 76 52
ROPINIROLE HCL 70 70 78 118
CIPROFLOXACIN HCL 67 49 79 77
GLIPIZIDE 66 54 80 57
LIDODERM 65 65 81 170
FLUTICASONE PROPIONATE 65 60 81 46
TIMOLOL MALEATE 64 64 83 359
ALBUTEROL SULFATE 63 61 84 128
SSD 62 56 85 387
PANTOPRAZOLE SODIUM 62 41 85 22
CLOTRIMAZOLE-BETAMETHASONE 61 57 87 135
AMOXICILLIN 61 61 87 108
INSULIN SYRINGE 61 60 87 109
MONOJECT INSULIN SAFETY SYRNG 61 51 87 310
OLANZAPINE 60 59 91 106
SEROQUEL 60 57 91 161
DIVALPROEX SODIUM 59 56 93 99
OXYBUTYNIN CHLORIDE 56 56 94 151
VENLAFAXINE HCL ER 56 53 94 84
SPIRIVA 56 56 94 40
DOXYCYCLINE HYCLATE 55 51 97 147
SPIRONOLACTONE 55 53 97 80
THERMAZENE 54 54 99 466
LANTUS SOLOSTAR 54 43 99 102
CILOSTAZOL 53 53 101 301
ADVAIR DISKUS 53 41 101 35
ZOLPIDEM TARTRATE 52 51 103 24
DORZOLAMIDE-TIMOLOL 52 52 103 399
PRADAXA 52 52 103 205
BUSPIRONE HCL 51 51 106 129
ACTOS 51 48 106 110
AGGRENOX 50 50 108 182
EXELON 50 50 108 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.